OCUL - Spark Newswire

2 minute read

Ocular Therapeutix And 2 Other Penny Stocks Insiders Are Aggressively Buying

November 10, 6:41 AM

The Dow Jones dipped by more than 600 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

MTCR

7 minute read

Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday

By Lisa Levin

November 9, 6:08 AM

Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.

AAON

5 minute read

Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

November 8, 1:51 PM

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.

AAON

1 minute read

Ocular Therapeutix Q3 EPS $(0.31) Misses $(0.24) Estimate, Sales $11.91M Miss $14.27M Estimate

By Michael Horton

November 7, 5:05 PM

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.24) by 29.17 percent. This is a 34.78 percent decrease over losses of $(0.23) per share

OCUL

13 minute read

Earnings

Earnings Scheduled For November 7, 2022

By Benzinga Insights

November 7, 4:59 AM

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.

AAON

1 minute read

Earnings

A Preview Of Ocular Therapeutix’s Earnings

By Benzinga Insights

November 4, 12:14 PM

Ocular Therapeutix (NASDAQ:OCUL) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Ocular Therapeutix will report an earnings per share (EPS) of $-0.24.

OCUL

6 minute read

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday

By Lisa Levin

October 3, 3:24 AM

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

AAN

4 minute read

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

September 30, 12:06 PM

Gainers

AEHL

6 minute read

Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday

By Lisa Levin

September 30, 4:49 AM

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.

$APE

1 minute read

Traders Speculate Circulation Of Tweet Of Ocular Therapeutix Presentation Today At AAO; Shares Spike Higher

By Benzinga Newsdesk

September 29, 3:41 PM

https://twitter.com/buysidebio/status/1575568356823822336

OCUL

Feed Symbols: OCUL